Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,959 papers from all fields of science
Search
Sign In
Create Free Account
SL 1250
Known as:
SL-1250
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
New AntitumorlmidazoleDerivative , 5-Carbamoyl-1 H-imidazol-4-yI Piperonylate , as an Inhibitorof PurineSynthesisand Its Activation by Adenine Phosphoribosyltransferas &
MasaruFukui
,
M. Inaba
,
S. Tsukagoshi
,
Yoshio Sakural
2006
Corpus ID: 17541230
The mechanism of action of 5-carbamoyl-i H-imidazol-4-yI piperonylate (SL-i 250), which has a broad antitumor spec trum, was…
Expand
1982
1982
New antitumor imidazole derivative, 5-carbamoyl-1H-imidazol-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphoribosyltransferase.
M. Fukui
,
M. Inaba
,
S. Tsukagoshi
,
Y. Sakurai
Cancer Research
1982
Corpus ID: 32798718
The mechanism of action of 5-carbamoyl-1H-imidazol-4-yl piperonylate (SL-1250), which has a broad antitumor spectrum, was…
Expand
1982
1982
Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
M. Inaba
,
M. Fukui
,
N. Yoshida
,
S. Tsukagoshi
,
Y. Sakurai
Cancer Research
1982
Corpus ID: 25828307
Two new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate (SL-1250) and 4-carbamoylimidazolium 5-olate (SM-108), were…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE